Sphingolipids in multiple sclerosis

Arundhati Jana1, Kalipada Pahan

  • 1Department of Neurological Sciences, Rush University Medical Center, Cohn Research Building, Suite 320, 1735 West Harrison St., Chicago, IL 60612, USA.

Insights

Multiple sclerosis (MS) involves oligodendrocyte apoptosis, with sphingolipids like ceramide and sphingosine-1-phosphate playing key roles in central nervous system (CNS) damage and disease progression.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Biochemistry

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune CNS disease targeting myelin-forming oligodendrocytes.
  • Oligodendrocyte apoptosis is a critical event in MS pathogenesis, leading to glial activation and immune cell infiltration.
  • The sphingolipid signaling pathway is increasingly recognized for its role in cell death and CNS disease.

Purpose of the Study:

  • To review the current understanding of sphingolipid metabolism and function in the context of MS.
  • To highlight the roles of ceramide and sphingosine-1-phosphate as key mediators in MS pathogenesis.
  • To compile recent findings on sphingolipids' involvement in oligodendrocyte apoptosis and CNS inflammation.

Main Methods:

  • Literature review and synthesis of existing research on sphingolipids and MS.
  • Analysis of the sphingolipid signal transduction pathway, including enzymes like sphingomyelinase and ceramidase.
  • Discussion of the roles of ceramide and sphingosine-1-phosphate as signaling molecules.

Main Results:

  • Sphingolipids, particularly ceramide and sphingosine-1-phosphate, are implicated in oligodendrocyte apoptosis and CNS inflammation in MS.
  • These molecules act as critical lipid second messengers regulating cell survival and death pathways.
  • Dysregulation of sphingolipid metabolism contributes to the pathogenic processes observed in MS.

Conclusions:

  • Sphingolipids are central players in the complex pathogenesis of multiple sclerosis.
  • Targeting sphingolipid pathways may offer novel therapeutic strategies for MS.
  • Further research into sphingolipid metabolism is crucial for understanding and treating MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
Membrane Lipids01:32

Membrane Lipids

Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...